ArticleBritish journal of pharmacology2005

Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.

Loredana Riganti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.